Results 61 to 70 of about 264,442 (390)

Sex differences and atrial fibrillation in heart failure with reduced versus preserved ejection fraction [PDF]

, 2021
Heart failure is a major public health problem. Patients with heart failure often experience dyspnoea, fatigue and/or have peripheral oedema. The prognosis of heart failure remains poor, with a severely impaired quality of life, frequent hospitalizations
Santema, Bernadet
core   +1 more source

Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction

Journal of Cardiovascular Development and Disease, 2023
Heart failure with reduced ejection fraction is a chronic and progressive syndrome that continues to be a substantial financial burden for health systems in Western countries. Despite remarkable advances in pharmacologic and device-based therapy over the
Luigi Falco, Benedetta Brescia, Dario Catapano, Maria Luigia Martucci, Fabio Valente, Rita Gravino, Carla Contaldi, Giuseppe Pacileo, Daniele Masarone   +8 more
doaj   +1 more source

Sacubitril and valsartan fixed combination to reduce heart failure events in post-acute myocardial infarction patients [PDF]

, 2017
Heart failure is a term used to define a constellation of symptoms and signs that are commonly attributed to the inability of the heart to produce a cardiac output that meets the demands of the body. It remains a deadly disease, affecting between 1-2% of
Lang, C. C., Zaid Iskandar, M.
core   +2 more sources

Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes [PDF]

, 2017
Purpose: The prevalence and consequences of prediabetic dysglycemia and undiagnosed diabetes is unknown in patients with heart failure (HF) and preserved ejection fraction (HFpEF) and has not been compared to heart failure and reduced ejection ...
Christopher B. Granger, John J. V. McMurray, Karl Swedberg, Lars Køber, Marc A. Pfeffer, Matthew M. Y. Lee, null null, Pardeep S. Jhund, Salim Yusuf, Scott D. Solomon, Søren L. Kristensen   +10 more
core   +3 more sources

Prediction models and risk scores in different types of heart failure: a review

Frontiers in Medicine
BackgroundHeart failure (HF) is a leading cause of global disease burden and mortality. Accurate prognosis assessment is critical for reducing the risk of adverse events.
Yue Wei, Siyu Liu, Yunying Mu, Xiaoyu Liang, Ziyi Chen, Yongcheng Liu, Guoju Dong, Guoju Dong   +7 more
doaj   +1 more source

Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study. [PDF]

, 2017
BackgroundApproximately half of the patients presenting with new-onset heart failure (HF) have HF with preserved left ventricular ejection fraction (HFpEF) and HF with mid-range left ventricular ejection fraction (HFmrEF).
Amurthur, Badri, Anand, Inder S, Ardell, Jeffrey L, DiCarlo, Lorenzo A, KenKnight, Bruce H, Kumar, H Uday, Libbus, Imad, Mittal, Sanjay, Premchand, Rajendra K   +8 more
core   +1 more source

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.

Circulation, 2019
Outcome trials in patients with type 2 diabetes mellitus have demonstrated reduced hospitalizations for heart failure (HF) with sodium-glucose co-transporter-2 inhibitors.
M. Nassif, Sheryl L. Windsor, F. Tang, Yevgeniy Khariton, M. Husain, S. Inzucchi, D. McGuire, B. Pitt, B. Scirica, B. Austin, M. Drazner, Michael W Fong, M. Givertz, R. Gordon, R. Jermyn, S. Katz, S. Lamba, D. Lanfear, S. Larue, J. Lindenfeld, M. Malone, K. Margulies, R. Mentz, R. Mutharasan, M. Pursley, G. Umpierrez, M. Kosiborod, A. Malik, Nannette Wenger, Modele O Ogunniyi, P. Vellanki, B. Murphy, J. Newman, J. Hartupee, Charu Gupta, Marcela Goldsmith, Paramdeep S. Baweja, M. Montero, S. Gottlieb, M. Costanzo, Thanh Hoang, A. Warnock, L. Allen, Wilson Tang, Horng H. Chen, J. M. Cox   +45 more
semanticscholar   +1 more source

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2019
Background: Although central apneas (CA) and obstructive apneas (OA) are highly prevalent in heart failure (HF), a comparison of apnea prevalence, predictors and clinical correlates in the whole HF spectrum, including HF with reduced ejection fraction ...
Chiara Borrelli, Chiara Borrelli, Chiara Borrelli, Francesco Gentile, Paolo Sciarrone, Gianluca Mirizzi, Gianluca Mirizzi, Giuseppe Vergaro, Giuseppe Vergaro, Nicolò Ghionzoli, Francesca Bramanti, Giovanni Iudice, Claudio Passino, Claudio Passino, Michele Emdin, Michele Emdin, Alberto Giannoni, Alberto Giannoni   +17 more
doaj   +1 more source

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study

ESC Heart Failure, 2020
Aims Changes in echocardiographic parameters and biomarkers of cardiac and venous pressures or estimated plasma volume during hospitalization associated with decongestive treatments in acute heart failure (AHF) patients with either preserved left ...
Eiichi Akiyama, Raphaël Cinotti, Kamilė Čerlinskaitė, Lucas N.L. Van Aelst, Mattia Arrigo, Rui Placido, Tahar Chouihed, Nicolas Girerd, Faiez Zannad, Patrick Rossignol, Marc Badoz, Jean‐Marie Launay, Etienne Gayat, Alain Cohen‐Solal, Carolyn S.P. Lam, Jeffrey Testani, Wilfried Mullens, Gad Cotter, Marie‐France Seronde, Alexandre Mebazaa   +19 more
doaj   +1 more source

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata

European Journal of Heart Failure, 2022
In older patients, guideline‐directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (
D. Stolfo, L. Lund, P. Becher, N. Orsini, T. Thorvaldsen, L. Benson, C. Hage, U. Dahlström, G. Sinagra, G. Savarese   +9 more
semanticscholar   +1 more source